Inventiva (IVA) Revenue & Revenue Breakdown
Inventiva Revenue Highlights
Latest Revenue (Y)
$17.50M
Latest Revenue (Q)
$15.58M
Main Geography (Y)
JAPAN
Inventiva Revenue by Period
Inventiva Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 43.69% |
| 2022-12-31 | - | 190.39% |
| 2021-12-31 | - | 1027.42% |
| 2020-12-31 | - | -94.68% |
| 2019-12-31 | - | 118.89% |
| 2018-12-31 | - | -50.97% |
| 2017-12-31 | - | -30.96% |
| 2016-12-31 | - | 93.77% |
| 2015-12-31 | - | 48.49% |
| 2014-12-31 | - | 7.13% |
| 2013-12-31 | - | - |
Inventiva generated $17.50M in revenue during NA 2023, up 43.69% compared to the previous quarter, and up 547.39% compared to the same period a year ago.
Inventiva Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 719.36% |
| 2023-06-30 | - | -84.30% |
| 2022-12-31 | - | 17977.61% |
| 2022-06-30 | - | -98.35% |
| 2021-12-31 | - | 6138.46% |
| 2021-06-30 | - | -12.16% |
| 2021-03-31 | - | -64.93% |
| 2020-12-31 | - | 185.14% |
| 2020-06-30 | - | -14.94% |
| 2020-03-31 | - | -98.46% |
| 2019-12-31 | - | 324.98% |
| 2019-06-30 | - | -23.81% |
| 2019-03-31 | - | -45.70% |
| 2018-12-31 | - | -22.49% |
| 2018-06-30 | - | 420.11% |
| 2018-03-31 | - | -84.77% |
| 2017-06-30 | - | 221.83% |
| 2017-03-31 | - | -65.35% |
| 2017-01-31 | - | -30.16% |
| 2016-06-30 | - | 185.26% |
| 2016-03-31 | - | -68.92% |
| 2016-01-31 | - | 523.38% |
| 2015-09-30 | - | -66.75% |
| 2015-06-30 | - | 200.73% |
| 2015-03-31 | - | -75.60% |
| 2015-01-31 | - | 508.64% |
| 2014-09-30 | - | - |
| 2014-06-30 | - | - |
| 2014-03-31 | - | - |
| 2014-01-31 | - | 7.13% |
| 2013-09-30 | - | - |
| 2013-06-30 | - | - |
| 2013-03-31 | - | - |
| 2013-01-31 | - | - |
Inventiva generated $15.58M in revenue during Q4 2023, up 719.36% compared to the previous quarter, and up 23963.08% compared to the same period a year ago.
Inventiva Revenue Breakdown
Inventiva Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 |
|---|---|---|
| China | - | - |
| France | - | - |
| JAPAN | - | - |
Latest
Inventiva's latest annual revenue breakdown by geography, as of Dec 23: JAPAN (72.95%), China (26.38%), and France (0.68%).
Inventiva Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IMCR | Immunocore | - | - |
| ACLX | Arcellx | - | - |
| IPHA | Innate Pharma | - | - |
| IVA | Inventiva | - | - |
| NAMS | NewAmsterdam Pharma Company | - | - |
| JANX | Janux Therapeutics | - | - |
| VRCA | Verrica Pharmaceuticals | - | - |
| HCWB | HCW Biologics | - | - |
| INBX | Inhibrx Biosciences | - | - |
| ANEB | Anebulo Pharmaceuticals | - | - |
| RZLT | Rezolute | - | - |
| CGEM | Cullinan Oncology | - | - |
| LIAN | LianBio | - | - |
| PCVX | Vaxcyte | - | - |
| DICE | DICE Therapeutics | - | - |
| ELYM | Eliem Therapeutics | - | - |
| VTYX | Ventyx Biosciences | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| VIGL | Vigil Neuroscience | - | - |
| GLUE | Monte Rosa Therapeutics | - | - |
| CMPX | Compass Therapeutics | - | - |
| EWTX | Edgewise Therapeutics | - | - |